These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3087790)

  • 21. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Induction of ovulation with subcutaneous pulsatile administration of human menopausal gonadotropin].
    Nakamura Y; Kido S; Kowaguchi Y; Tamaoka Y; Hara S; Higuchi Y; Shiraishi S; Yoshimura Y; Iizuka R; Oda T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1169-76. PubMed ID: 3928777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
    Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL; Farhi J; Homburg R; Jacobs HS
    Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative].
    Steck T; Würfel W; Witteler M; Albert P
    Geburtshilfe Frauenheilkd; 1991 May; 51(5):373-8. PubMed ID: 1907938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovulation induction in clomiphene nonresponsive patients: the place of pulsatile gonadotropin-releasing hormone in clinical practice.
    Molloy BG; Hancock KW; Glass MR
    Fertil Steril; 1985 Jan; 43(1):26-33. PubMed ID: 3917407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH; Sy L; Cannon W
    Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. British Fertility Society. 'Ovulation induction in WHO Type 1 anovulation: Guidelines for practice'. Produced on behalf of the BFS Policy and Practice Committee.
    Yasmin E; Davies M; Conway G; Balen AH; British Fertility Society
    Hum Fertil (Camb); 2013 Dec; 16(4):228-34. PubMed ID: 24245485
    [No Abstract]   [Full Text] [Related]  

  • 30. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal progesterone administration before ovulation induction with exogenous gonadotropins in polycystic ovarian syndrome.
    Buckler HM; Phillips SE; Cameron IT; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1988 Aug; 67(2):300-6. PubMed ID: 3134388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulsatile intravenous gonadotropin-releasing hormone for ovulation-induction in infertile women. II. Analysis of follicular and luteal phase responses.
    Jansen RP; Handelsman DJ; Boylan LM; Conway A; Shearman RP; Fraser IS; Anderson JC
    Fertil Steril; 1987 Jul; 48(1):39-44. PubMed ID: 3109964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A modified hMG-GnRH method for the induction of ovulation in infertile women with severe hypogonadotropic amenorrhea.
    Yokoi N; Uemura T; Murase M; Kondoh Y; Ishikawa M; Hirahara F
    Endocr J; 2002 Apr; 49(2):159-64. PubMed ID: 12081234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulsatile subcutaneous low-dose gonadotropin-releasing hormone treatment of anovulatory infertility.
    Skarin G; Nillius SJ; Wide L
    Fertil Steril; 1983 Oct; 40(4):454-60. PubMed ID: 6413261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.
    Balen AH; Braat DD; West C; Patel A; Jacobs HS
    Hum Reprod; 1994 Aug; 9(8):1563-70. PubMed ID: 7989523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.
    Cignitti M; Mazzarini A; Pini A; Garzetti GG; Romanini C
    Acta Eur Fertil; 1990; 21(5):235-8. PubMed ID: 2132474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology.
    Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G
    Gynecol Endocrinol; 2016 Dec; 32(12):999-1004. PubMed ID: 27258574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.